IBPM005IX (Inbiopro Solutions)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIBPM005IX (Inbiopro Solutions)
Drug Alias NameIBPM005IX (biosimilar) - Inbiopro SolutionsIBPM 005IX
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibody
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsCrohn DiseaseArthritis, RheumatoidArthritis, Juvenile +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesInbiopro Solutions
China Registration ClassN/A

Develop Information

Active CompaniesInbiopro Solutions
Inactive CompaniesN/A
Active IndicationsCrohn DiseaseArthritis, RheumatoidArthritis, Juvenile +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A